Literature DB >> 1323673

Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection.

G Lawton1, S Thomas, J Schonrock, F Monsour, I Frazer.   

Abstract

The prevalence of six genital genotypes of HPV was assessed in the clinically normal oral mucosa of an adult Caucasian population, and three methods of sample collection compared. HPV DNA was detected in the mouth of 60% of 60 subjects. HPV 16 was the most prevalent genotype, and positive samples were found most frequently in men over 50. A 3% sucrose mouthwash produced more positive results (51%) than mucosal scrapes of three separate sites (45%) or buccal mucosal biopsies (12%). There was no association of a positive result for HPV DNA with any particular mucosal site. A mouthwash was the preferred single screening method for epidemiologic studies of HPV DNA in the mouth, but the greatest yield of positive samples was obtained if multiple sampling techniques were employed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323673     DOI: 10.1111/j.1600-0714.1992.tb01008.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  19 in total

1.  Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples.

Authors:  Tatevik R Broutian; Xin He; Maura L Gillison
Journal:  J Clin Virol       Date:  2011-01-26       Impact factor: 3.168

2.  Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28.

Authors:  E Pegoraro; J Whitaker; P Mowery-Rushton; U Surti; M Lanasa; E P Hoffman
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

3.  Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions.

Authors:  Lucia Giovannelli; Giuseppina Campisi; Giuseppe Colella; Giuseppina Capra; Chiara Di Liberto; Maria Pia Caleca; Domenica Matranga; Matteo D'Angelo; Lorenzo Lo Muzio; Pietro Ammatuna
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

4.  Prognostic value of clinical findings in histologically verified adult-onset laryngeal papillomas.

Authors:  L M Aaltonen; J Peltomaa; H Rihkanen
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

5.  Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR.

Authors:  Gypsyamber D'Souza; Elizabeth Sugar; William Ruby; Patti Gravitt; Maura Gillison
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study.

Authors:  Ralf B Uken; Oliver Brummer; Carolin von Schubert-Bayer; Thomas Brodegger; Ingo U Teudt
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-09       Impact factor: 2.503

7.  Impacts of HIV infection and long-term use of antiretroviral therapy on the prevalence of oral human papilloma virus type 16.

Authors:  Korntip Amornthatree; Hutcha Sriplung; Winyou Mitarnun; Wipawee Nittayananta
Journal:  J Oral Pathol Med       Date:  2011-11-18       Impact factor: 4.253

8.  Rates and determinants of oral human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Stephen M Schwartz; Stephen Hawes; James P Hughes; Qinghua Feng; Michael E Stern; Sandra O'Reilly; Shu-Kuang Lee; Long Fu Xi; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

9.  Epidemiology of Human Papillomavirus Detected in the Oral Cavity and Fingernails of Mid-Adult Women.

Authors:  Tsung-chieh Jane Fu; James P Hughes; Qinghua Feng; Ayaka Hulbert; Stephen E Hawes; Long Fu Xi; Stephen M Schwartz; Joshua E Stern; Laura A Koutsky; Rachel L Winer
Journal:  Sex Transm Dis       Date:  2015-12       Impact factor: 2.830

10.  Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges.

Authors:  Katherine H Parker; Troy J Kemp; Yuanji Pan; Zhen Yang; Anna R Giuliano; Ligia A Pinto
Journal:  Vaccine       Date:  2018-04-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.